Siao Muk Cheng

862 total citations
26 papers, 598 citations indexed

About

Siao Muk Cheng is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Siao Muk Cheng has authored 26 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Siao Muk Cheng's work include Autophagy in Disease and Therapy (7 papers), Cell death mechanisms and regulation (5 papers) and RNA Interference and Gene Delivery (4 papers). Siao Muk Cheng is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), Cell death mechanisms and regulation (5 papers) and RNA Interference and Gene Delivery (4 papers). Siao Muk Cheng collaborates with scholars based in Taiwan, New Zealand and United States. Siao Muk Cheng's co-authors include Chun Hei Antonio Cheung, Euphemia Leung, Yung-Chieh Chang, Tzu‐Yu Lin, Shang‐Hung Chen, F. Tsai, Chien-Chang Huang, Yi-Chun Huang, Mohane Selvaraj Coumar and Sailu Sarvagalla and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Pharmacology and Journal of Investigative Dermatology.

In The Last Decade

Siao Muk Cheng

23 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siao Muk Cheng Taiwan 12 415 136 125 110 62 26 598
Qiumeng Liu China 15 403 1.0× 132 1.0× 94 0.8× 146 1.3× 59 1.0× 33 616
Yung-Chieh Chang Taiwan 10 343 0.8× 137 1.0× 100 0.8× 76 0.7× 55 0.9× 15 520
Ranadip Mandal Germany 9 342 0.8× 120 0.9× 73 0.6× 83 0.8× 80 1.3× 11 516
Qingqu Guo China 14 326 0.8× 247 1.8× 84 0.7× 146 1.3× 65 1.0× 27 613
Xu Guang Yan Australia 15 424 1.0× 147 1.1× 83 0.7× 156 1.4× 109 1.8× 22 590
Laura Antonucci Italy 14 446 1.1× 209 1.5× 118 0.9× 120 1.1× 101 1.6× 21 746
Olga Surova Sweden 11 404 1.0× 118 0.9× 59 0.5× 163 1.5× 47 0.8× 17 564
Zhao-na Yang China 8 255 0.6× 85 0.6× 98 0.8× 89 0.8× 63 1.0× 8 460
Xuxu Sun China 9 585 1.4× 181 1.3× 85 0.7× 137 1.2× 88 1.4× 20 724

Countries citing papers authored by Siao Muk Cheng

Since Specialization
Citations

This map shows the geographic impact of Siao Muk Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siao Muk Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siao Muk Cheng more than expected).

Fields of papers citing papers by Siao Muk Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siao Muk Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siao Muk Cheng. The network helps show where Siao Muk Cheng may publish in the future.

Co-authorship network of co-authors of Siao Muk Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Siao Muk Cheng. A scholar is included among the top collaborators of Siao Muk Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siao Muk Cheng. Siao Muk Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chuan, Ya-Chin Hou, Ching-Liang Shen, et al.. (2025). Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells. Molecular Cancer. 24(1). 25–25. 3 indexed citations
2.
Li, Junyi, et al.. (2025). Seeing means feeling? The transformation mechanism from visual attention to emotional experience toward linguistic landscape in cultural district. Journal of Destination Marketing & Management. 37. 101007–101007. 1 indexed citations
3.
Lin, Jerry Chun‐Wei, Siao Muk Cheng, Wentai Liu, et al.. (2025). Distal electrical stimulation enhances neuromuscular reinnervation and satellite cell differentiation for functional recovery. Stem Cell Research & Therapy. 16(1). 322–322.
4.
Cheng, Siao Muk, Shiou‐Lan Chen, T.‐S. LIN, et al.. (2025). Functional Diversity of Two Novel Embryonic Microglial Subpopulations and Their Developmental Trajectories in Developing Mouse Brains. Glia. 73(11). 2236–2252.
5.
Lin, Yu‐Chen, Alexandros Onoufriadis, Hans I‐Chen Harn, et al.. (2024). Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin. British Journal of Dermatology. 191(2). 252–260. 4 indexed citations
6.
Yang, Wen‐Bin, Chia-Hung Chien, Jian‐Ying Chuang, et al.. (2024). CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity. Cell Death and Disease. 15(6). 434–434. 2 indexed citations
7.
Hwang, Daw‐Yang, Chao‐Chun Yang, Siao Muk Cheng, et al.. (2024). Profibrotic Subsets of SPP1+ Macrophages and POSTN+ Fibroblasts Contribute to Fibrotic Scarring in Acne Keloidalis. Journal of Investigative Dermatology. 144(7). 1491–1504.e10. 14 indexed citations
8.
Kung, Mei‐Lang, et al.. (2024). Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice. Communications Biology. 7(1). 594–594. 3 indexed citations
9.
Cheng, Siao Muk, Yung‐Yeh Su, Nai‐Jung Chiang, et al.. (2024). Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan. Journal of Biomedical Science. 31(1). 21–21. 4 indexed citations
10.
Chien, Chia-Hung, Wen‐Bin Yang, Jian‐Ying Chuang, et al.. (2022). SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma. Journal of Experimental & Clinical Cancer Research. 41(1). 220–220. 11 indexed citations
11.
Lin, Ming‐Yen, Siao Muk Cheng, Chi‐Chih Hung, et al.. (2022). PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan. npj Genomic Medicine. 7(1). 40–40. 7 indexed citations
12.
Lim, Lee‐Moay, Wen‐Yu Chung, Daw‐Yang Hwang, et al.. (2022). Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation. Journal of Translational Medicine. 20(1). 324–324. 4 indexed citations
13.
Yang, Wen‐Bin, Kwang‐Yu Chang, Jung‐Shun Lee, et al.. (2022). HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells. Journal of Experimental & Clinical Cancer Research. 41(1). 47–47. 19 indexed citations
14.
Cheng, Siao Muk, et al.. (2021). YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair. Pharmacological Research. 166. 105474–105474. 17 indexed citations
15.
Cheung, Chun Hei Antonio, et al.. (2020). Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE. Journal of Biomedical Science. 27(1). 31–31. 78 indexed citations
16.
Chang, Yung-Chieh, Tsung-Han Yang, Siao Muk Cheng, et al.. (2020). The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells. Toxicology and Applied Pharmacology. 401. 115080–115080. 16 indexed citations
17.
Lin, Tzu‐Yu, Shang‐Hung Chen, Sailu Sarvagalla, et al.. (2019). BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy. 16(7). 1296–1313. 96 indexed citations
18.
Cheng, Siao Muk, Shang‐Hung Chen, Chien‐Feng Li, et al.. (2016). Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells. Frontiers in Pharmacology. 7. 81–81. 53 indexed citations
19.
Cheung, Chun Hei Antonio, et al.. (2016). Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study. OncoTargets and Therapy. 9. 2601–2601. 10 indexed citations
20.
Cheung, Chun Hei Antonio, Chien-Chang Huang, F. Tsai, et al.. (2013). Survivin – biology and potential as a therapeutic target in oncology. OncoTargets and Therapy. 6. 1453–1453. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026